Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuropsychological follow-up of Isoconda ICU sedation trial
DRKS00014030Phase 3Recruiting
- Sponsor
- Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum des Saarlandes
- Start
- Nov 2018
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in post-intensive care syndrome (PICS), delirium, acute stress reaction (ASR) and 2 more comparing Isoflurane sedation with Propofol sedation (2 arms). Primary endpoint: Neuropsychological outcome at 1 month after ICU discharge. Started Nov 2018; status: recruiting.
02
Drugs
isofluranepropofol
03
Conditions
post-intensive care syndrome (PICS)deliriumacute stress reaction (ASR)major depressive episode (MDE)Care-provider dependency
Beyond the preview
Go deeper on DRKS00014030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014030.